Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.
Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
MOMA Therapeutics operates as a biotechnology company.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Third Rock Ventures has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Third Rock Ventures's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Genetics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Revolution Medicines received $1.5B in a Post-IPO Equity round. Third Rock Ventures's total known invested capital is $6.1B.
Third Rock Ventures's average investment size is $136.5M across its portfolio of 50 companies.
Recent Third Rock Ventures portfolio additions include Red Arrow Therapeutics, Abata Therapeutics, Septerna, Rhythm Pharmaceuticals, Marea Therapeutics. These companies were founded in 2020 or later.